DNA virus MicroRNA and methods for inhibiting same
AssigneeThe Rockefeller University
InventorsSebastien Pfeffer, Thomas Tuschl
Life of this patent
Estimating the term…
Abstract
The invention relates to isolated nucleic acid molecules comprising the sequence of a human cytomegalovirus microRNA. In another embodiment, the invention relates to single stranded DNA virus microRNA molecules comprising the sequence of a human cytomegalovirus microRNA. The invention also relates to the anti-DNA virus microRNA molecules.
Claims10
An isolated nucleic acid Epstein Barr virus (EBV) microRNA molecule having a maximum of 50 nucleotides comprising a sequence selected from the group consisting of SEQ ID NOS:
- 1 and 3-5, wherein at least one ribonucleotide in said sequence is modified to confer nuclease resistance as compared to the unmodified naturally occurring microRNA, and wherein the modification of the ribonucleotide is selected from the group consisting of a C1 to C4 alkyl group substituted at the 2′ position, a C1 to C4 alkoxy-C1 to C4 alkyl group substituted at the 2′ position, and a methylene bridge between the 2′-oxygen atom and the 4′-carbon atom.
An isolated nucleic acid Epstein Barr virus (EBV) microRNA molecule selected from the group consisting of SEQ ID NOS:
- 1 and 3-5, at least one of the ribonucleotides in said sequence is modified-to confer nuclease resistance as compared to the unmodified naturally occurring microRNA, and wherein the modification of the ribonucleotide is selected from the group consisting of a C1 to C4 alkyl group substituted at the 2′ position, a C1 to C4 alkoxy-C1 to C4 alkyl group substituted at the 2′ position, or a methylene bridge between the 2′-oxygen atom and the 4′-carbon atom.
Dependencies are inferred from the claim text.